“Clinical Safety and Pharmacokinetics of FMX101 4% Topical Minocycline Foam in Pediatric Patients for the Treatment of Moderate-to-Severe Acne Vulgaris”. 2019. SKIN The Journal of Cutaneous Medicine 3 (November): S2. https://doi.org/10.25251/skin.3.supp.2.